Table of Contents
1. Executive Summary
2. Global Liquid Biopsy Market Background and Classifications
2.1: Introduction, Background and Classification
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends and Forecasts
3.2: Global Liquid Biopsy Market Trends and Forecast
3.3: Global Liquid Biopsy Market by Product
3.3.1: Assay Kits
3.3.2: Instruments
3.3.3: Services
3.4: Global Liquid Biopsy Market by Circulating Biomarker
3.4.1: Circulating Tumor Cells (CTCs)
3.4.2: Circulating Tumor DNA (ctDNA)
3.4.3: Cell-Free DNA (cfDNA)
3.4.4: Extracellular Vesicles (EVs)
3.4.5: Other Circulating Biomarkers
3.5: Global Liquid Biopsy Market by Application
3.5.1: Oncology
3.5.1.1: Lung Cancer
3.5.1.2: Breast Cancer
3.5.1.3: Colorectal Cancer
3.5.1.4: Prostate Cancer
3.5.1.5: Liver Cancer
3.5.1.6: Other Cancer
3.5.2: Non-Cancer
3.6: Global Liquid Biopsy Market by Clinical Application
3.6.1: Early Cancer Screening
3.6.2: Therapy Selection
3.6.3: Treatment Monitoring
3.6.4: Recurrence Monitoring
3.7: Global Liquid Biopsy Market by End User
3.7.1: Reference Laboratories
3.7.2: Hospitals and Physician Laboratories
3.7.3: Academic and Research Centers
3.7.4: Other End Users
4. Market Trends and Forecast Analysis from 2018 to 2030
4.1: Global Liquid Biopsy Market by Region
4.2: North American Liquid Biopsy Market Trends and Forecast
4.2.1: North American Liquid Biopsy Market by Product
4.2.2: North American Liquid Biopsy Market by Circulating Biomarker
4.2.3: North American Liquid Biopsy Market by Application
4.2.4: North American Liquid Biopsy Market by Clinical Application
4.2.5: North American Liquid Biopsy Market by End Use
4.2.6: United States Liquid Biopsy Market
4.2.7: Canadian Liquid Biopsy Market
4.2.8: Mexican Liquid Biopsy Market
4.3: European Liquid Biopsy Market Trends and Forecast
4.3.1: European Liquid Biopsy Market by Product
4.3.2: European Liquid Biopsy Market by Circulating Biomarker
4.3.3: European Liquid Biopsy Market by Application
4.3.4: European Liquid Biopsy Market by Clinical Application
4.3.5: European Liquid Biopsy Market by End Use
4.3.6: United Kingdom Liquid Biopsy Market
4.3.7: German Liquid Biopsy Market
4.3.8: French Liquid Biopsy Market
4.3.9: Italian Liquid Biopsy Market
4.3.10: Spanish Liquid Biopsy Market
4.4: APAC Liquid Biopsy Market Trends and Forecast
4.4.1: APAC Liquid Biopsy Market by Product
4.4.2: APAC Liquid Biopsy Market by Circulating Biomarker
4.4.3: APAC Liquid Biopsy Market by Application
4.4.4: APAC Liquid Biopsy Market by Clinical Application
4.4.5: APAC Liquid Biopsy Market by End Use
4.4.6: Japanese Liquid Biopsy Market
4.4.7: Chinese Liquid Biopsy Market
4.4.8: Indian Liquid Biopsy Market
4.5: ROW Liquid Biopsy Market Trends and Forecast
4.5.1: ROW Liquid Biopsy Market by Product
4.5.2: ROW Liquid Biopsy Market by Circulating Biomarker
4.5.3: ROW Liquid Biopsy Market by Application
4.5.4: ROW Liquid Biopsy Market by Clinical Application
4.5.5: ROW Liquid Biopsy Market by End Use
4.5.6: Brazilian Liquid Biopsy Market
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Liquid Biopsy Market by Product
6.1.2: Growth Opportunities for the Global Liquid Biopsy Market by Circulating Biomarker
6.1.3: Growth Opportunities for the Global Liquid Biopsy Market by Application
6.1.4: Growth Opportunities for the Global Liquid Biopsy Market by Clinical Application
6.1.5: Growth Opportunities for the Global Liquid Biopsy Market by End Use
6.1.6: Growth Opportunities for the Global Liquid Biopsy Market by Region
6.2: Emerging Trends in the Global Liquid Biopsy Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Licensing and Certification
6.3.3: Mergers, Acquisitions, Joint Ventures, and Other Collaborations in the Global Liquid Biopsy Market
7. Company Profiles of Leading Players
7.1: Bio-Rad Laboratories
7.2: QIAGEN
7.3: MDxHealth
7.4: Myriad Genetics
7.5: Biocept, Inc.
7.6: F. Hoffmann-La Roche Ltd.
7.7: Thermo Fisher Scientific Inc.
7.8: Illumina, Inc.
7.9: Cardiff Oncology
7.10: Guardant Health